LLY vs SCM · P/E 39, rev $22.97B vs P/E 10, rev $97.8M
Eli Lilly and Company (LLY) versus Stellus Capital Investment (SCM) — a side-by-side from cached financials, not a winner call.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Stellus Capital Investment (SCM) is a asset management company listed on NYSE.
Latest reported LLY revenue for 2026-06-30 was $22.97B. Net income was $7.09B. Revenue was up 16.0% from 2026-03-31 to 2026-06-30. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Latest reported SCM revenue for 2025-12-31 was $97.8M. Net income was $27.0M. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. SCM currently screens at market cap $244.6M and trailing P/E 10.2.
LLY currently screens at market cap $991.62B and trailing P/E 39.5. SCM currently screens at market cap $244.6M and trailing P/E 10.2.
Not investment advice. Open the LLY and SCM stock pages for the full models.
Not investment advice.